FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,893,000 | +68.0% | 182,993 | -24.1% | 0.15% | +63.8% |
| Q4 2020 | $4,104,000 | +166.7% | 241,243 | -26.3% | 0.09% | +147.4% |
| Q3 2020 | $1,539,000 | -22.9% | 327,414 | 0.0% | 0.04% | -17.4% |
| Q2 2020 | $1,997,000 | +250.4% | 327,414 | +30.3% | 0.05% | +228.6% |
| Q1 2020 | $570,000 | -50.6% | 251,216 | 0.0% | 0.01% | -39.1% |
| Q4 2019 | $1,153,000 | +55.6% | 251,216 | +31.4% | 0.02% | +35.3% |
| Q3 2019 | $741,000 | -35.7% | 191,237 | 0.0% | 0.02% | -37.0% |
| Q2 2019 | $1,153,000 | -55.0% | 191,237 | 0.0% | 0.03% | -55.0% |
| Q1 2019 | $2,563,000 | +44.1% | 191,237 | 0.0% | 0.06% | 0.0% |
| Q4 2018 | $1,779,000 | +5.1% | 191,237 | +57.3% | 0.06% | +25.0% |
| Q3 2018 | $1,692,000 | +13.6% | 121,576 | +29.1% | 0.05% | +37.1% |
| Q2 2018 | $1,489,000 | -8.0% | 94,200 | 0.0% | 0.04% | -22.2% |
| Q1 2018 | $1,618,000 | +17.6% | 94,200 | +50.0% | 0.04% | +25.0% |
| Q4 2017 | $1,376,000 | +61.9% | 62,800 | +201.9% | 0.04% | +71.4% |
| Q3 2017 | $850,000 | – | 20,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|